← Leaderboards
Brian H Annex
Augusta University
$19,823,799
Attributed
$22,673,940
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–23$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$22,673,940 · 11
By mechanism
R01$19,969,024 · 8
UH3$1,175,408 · 1
R33$1,164,336 · 1
R56$365,172 · 1
Top collaborators
- Brent A French4 shared
- Joseph Matthew Mcclung4 shared
Most similar at Augusta University
Same institution · by research overlap
- Joseph Matthew McClung$6,963,151
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsMedicalMuscleAtherosclerosisPeripheral Arterial DiseasePerfusionBlood FlowTissuesGrowthWalkingAngiogenesisPathway InteractionsDisorder ControlBaseIschemiaCellsUnited StatesReceptorArteriesUniversitiesPublic Health RelevanceTherapeutic AngiogenesisImpairmentPlasma
Grant awards (44)
Clinical Phenotyping and Disease Specific Sampling to Identify Non-coding RNAs for Human Therapeutics in PAD$723,849
R01 · FY2023 · HL · contact PI
Clinical Phenotyping and Disease Specific Sampling to Identify Non-coding RNAs for Human Therapeutics in PAD$733,094
R01 · FY2022 · HL · contact PI
Precision Medicine for Therapeutic Angiogenesis in Peripheral Arterial Disease: Targeting of the IL21R Pathway$724,231
R01 · FY2022 · HL · contact PI
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease$673,667
R01 · FY2022 · HL · contact PI
Clinical Phenotyping and Disease Specific Sampling to Identify Non-coding RNAs for Human Therapeutics in PAD$742,059
R01 · FY2021 · HL · contact PI
Precision Medicine for Therapeutic Angiogenesis in Peripheral Arterial Disease: Targeting of the IL21R Pathway$728,629
R01 · FY2021 · HL · contact PI
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease$673,667
R01 · FY2021 · HL · contact PI
Clinical Phenotyping and Disease Specific Sampling to Identify Non-coding RNAs for Human Therapeutics in PAD$761,832
R01 · FY2020 · HL · contact PI
Precision Medicine for Therapeutic Angiogenesis in Peripheral Arterial Disease: Targeting of the IL21R Pathway$732,895
R01 · FY2020 · HL · contact PI
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease$649,402
R01 · FY2020 · HL · contact PI
Precision Medicine for Therapeutic Angiogenesis in Peripheral Arterial Disease: Targeting of the IL21R Pathway$759,462
R01 · FY2019 · HL · contact PI
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease$713,852
R01 · FY2019 · HL · contact PI
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease$691,315
R01 · FY2017 · HL · contact PI
MicroRNA 93 in Peripheral Arterial Disease$395,000
R01 · FY2017 · HL · contact PI
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease$681,405
R01 · FY2016 · HL · contact PI
MicroRNA 93 in Peripheral Arterial Disease$395,000
R01 · FY2016 · HL · contact PI
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease$675,558
R01 · FY2015 · HL · contact PI
MicroRNA 93 in Peripheral Arterial Disease$389,075
R01 · FY2015 · HL · contact PI
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease$691,170
R01 · FY2014 · HL · contact PI
Reuse of ZD4054 for patients with symptomatic PAD$587,704
UH3 · FY2014 · TR · contact PI
MicroRNA 93 in Peripheral Arterial Disease$395,000
R01 · FY2014 · HL · contact PI
Reuse of ZD4054 for patients with symptomatic PAD$587,704
UH3 · FY2013 · TR · contact PI
Therapeutic Angiogenesis for Erectile Dysfunction$365,172
R56 · FY2009 · DK · contact PI
Systems Biology of Angiogenesis: from Molecules to Therapy$380,741
R33 · FY2008 · HL · contact PI
Skeletal Muscle Plasticity Following LVAD Support$351,716
R01 · FY2008 · HL · contact PI
Skeletal Muscle Plasticity Following LVAD Support$115,076
R01 · FY2008 · HL · contact PI
Skeletal Muscle Plasticity Following LVAD Support$463,054
R01 · FY2007 · HL · contact PI
Angiogenesis and Mechanisms of Exercise Training in PAD$457,100
R01 · FY2007 · HL · contact PI
Systems Biology of Angiogenesis: from Molecules to Therapy$394,636
R33 · FY2007 · HL · contact PI
Angiogenesis and Mechanisms of Exercise Training in Peripheral Arterial Disease$344,271
R01 · FY2007 · HL · contact PI
Therapeutic Angiogenesis for Erectile Dysfunction$131,193
R01 · FY2007 · DK · contact PI
Therapeutic Angiogenesis for Erectile Dysfunction$125,802
R01 · FY2007 · DK · contact PI
Angiogenesis and Mechanisms of Exercise Training in PAD$80,394
R01 · FY2007 · HL · contact PI
Angiogenesis and Mechanisms of Exercise Training in PAD$779,576
R01 · FY2006 · HL · contact PI
Skeletal Muscle Plasticity Following LVAD Support$415,229
R01 · FY2006 · HL · contact PI
Systems Biology of Angiogenesis: from Molecules to Therapy$388,959
R33 · FY2006 · HL · contact PI
Therapeutic Angiogenesis for Erectile Dysfunction$264,671
R01 · FY2006 · DK · contact PI
Angiogenesis and Mechanisms of Exercise Training in PAD$244,125
R01 · FY2006 · HL · contact PI
Angiogenesis and Mechanisms of Exercise Training in PAD$799,958
R01 · FY2005 · HL
Skeletal Muscle Plasticity Following LVAD Support$382,852
R01 · FY2005 · HL
Therapeutic Angiogenesis for Erectile Dysfunction$271,040
R01 · FY2005 · DK
Angiogenesis and Mechanisms of Exercise Training in PAD$772,112
R01 · FY2004 · HL
Therapeutic Angiogenesis for Erectile Dysfunction$271,040
R01 · FY2004 · DK
Angiogenesis and Mechanisms of Exercise Training in PAD$769,653
R01 · FY2003 · HL